User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Response to letter by Aramugakani et al.

  1. Vital Edward M., Dass Shouvik, Buch Maya H., Henshaw Karen, Pease Colin T., Martin Michael F., Ponchel Frederique, Rawstron Andrew C., Emery Paul, B cell biomarkers of rituximab responses in systemic lupus erythematosus : B Cell Biomarkers in Rituximab Therapy for SLE, 10.1002/art.30466
  2. Cheng Qingyu, Mumtaz Imtiaz M, Khodadadi Laleh, Radbruch Andreas, Hoyer Bimba F, Hiepe Falk, Autoantibodies from long-lived ‘memory’ plasma cells of NZB/W mice drive immune complex nephritis, 10.1136/annrheumdis-2013-203455
  3. Ferraccioli Gianfranco, Houssiau Frédéric A, Which B-cell subset should we target in lupus?, 10.1136/annrheumdis-2013-203827
  4. Arumugakani Gururaj, Vital Edward M, Md Yusof Md Yuzaiful, McGonagle Dennis G, Emery Paul, Response to: ‘Which B-cell subset should we target in lupus?’ by Ferraccioli and Houssiau, 10.1136/annrheumdis-2013-205096
Bibliographic reference Ferraccioli, Gianfranco ; Houssiau, Frédéric. Response to letter by Aramugakani et al.. In: Annals of the rheumatic diseases, Vol. 73, no.4, p. e21 (2014)
Permanent URL http://hdl.handle.net/2078.1/146052